Table 3.
Characteristics of Participants Stratified by Number of Lung Segments Showing Infiltrates
| Characteristic | <4 Seg., N = 132 | 4–8 Seg., N = 187 | >8 Seg., N = 119 | P-value |
|---|---|---|---|---|
| Gender | 0.500b | |||
| Male | 116/132 (88%) | 156/187 (83%) | 103/119 (87%) | |
| Female | 16/132 (12%) | 31/187 (17%) | 16/119 (13%) | |
| Age | 49.0 (43.0,54.2) | 51.0 (44.5,56.0) | 49.0 (43.0,56.0) | 0.300a |
| ELISPOT.TB | 82/108 (76%) | 136/164 (83%) | 72/104 (69%) | 0.032b |
| Sputum smear | 55/117 (47%) | 122/173 (71%) | 76/102 (75%) | <0.001b |
| Sputum TB-DNA | 62/103 (60%) | 137/160 (86%) | 78/95 (82%) | <0.001b |
| Sputum culture | 79/112 (71%) | 142/169 (84%) | 90/104 (87%) | 0.004b |
| WBC | 7.2 (6.1,8.5) | 7.8 (6.2,9.7) | 8.1 (6.8,10.4) | 0.004a |
| GRA% | 65.3 (59.6,71.2) | 69.9 (63.1,77.8) | 74.0 (67.4,80.8) | <0.001a |
| LYN% | 22.9 (18.5,29.2) | 17.5 (12.6,24.4) | 15.0 (10.3,20.6) | <0.001a |
| MONO% | 8.1 (6.2,10.1) | 9.2 (6.9,11.7) | 8.6 (6.5,10.2) | 0.012a |
| HGB | 137.5 (126.0,148.2) | 129.0 (113.5,140.0) | 125.0 (108.0,135.5) | <0.001a |
| ALB | 40.6 (38.0,42.9) | 38.4 (34.6,41.7) | 36.2 (32.1,40.0) | <0.001a |
| HbA1c | 10.5 (8.5,11.9) | 10.6 (8.3,12.8) | 11.4 (8.4,13.2) | 0.150a |
| FBG | 9.5 (7.4,12.2) | 9.4 (6.7,13.1) | 10.3 (7.0,13.6) | 0.500a |
| CRP | 12.5 (4.3,33.1) | 43.3 (16.9,85.9) | 63.5 (34.2,94.8) | <0.001a |
| PCT | 0.1 (0.03,0.1) | 0.1 (0.04,0.1) | 0.1 (0.05,0.2) | <0.001a |
Note: aKruskal–Wallis rank sum test, bChi-squared test.
Abbreviations: ELISPOT.TB, enzyme-linked immune-spot tuberculosis; WBC, white blood cell; GRA, neutrophilic granulocyte; LYN, lymphocyte; MONO, monocyte; HGB, hemoglobulin; ALB, albumin; FBG, free blood glucose; HbcA1, hemoglobin A1C; CRP, C-reactive protein; PCT, procalcitonin.